BHVN

Biohaven Ltd. Healthcare - Biotechnology Investor Relations →

YES

56.2% BELOW

↓ Approaching Was -55.5% last week

-15% -10% -5% 0% 5% 10% 15%+

Buy Threshold $26.51

14-Week RSI 35

Biohaven Ltd. (BHVN) closed at $11.60 as of 2026-02-02, trading 56.2% below its 200-week moving average of $26.51. This places BHVN in the extreme value zone. The stock is currently moving closer to the line, down from -55.5% last week. The 14-week RSI sits at 35, indicating neutral momentum.

Over the past 128 weeks of data, BHVN has crossed below its 200-week moving average 1 time. On average, these episodes lasted 49 weeks.

With a market cap of $1539 million, BHVN is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -522.1%. The stock trades at -71.6x book value.

Share count has increased 182.6% over three years, indicating dilution.

Over the past 2.6 years, a hypothetical investment of $100 in BHVN would have grown to $61, compared to $158 for the S&P 500. BHVN has returned -17.3% annualized vs 19.5% for the index, underperforming the broader market over this period.

In the past 12 months, corporate insiders have made 5 open-market purchases totaling $34,141,001. Multiple insiders purchased within a 30-day window — a cluster buy pattern that historically signals management confidence in the company's prospects. Notably, these purchases occurred while BHVN is trading below its 200-week moving average — insiders are buying when the market is most pessimistic.

Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.

Growth of $100: BHVN vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After BHVN Crosses Below the Line?

Each line shows $100 invested at the moment BHVN crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Insider Buying Activity

3 conviction buys in the past 12 months (purchases over $500K with meaningful position increases). 🔥 Cluster Buy Detected

Date	Insider	Title	Value	Shares	Position +%
2025-11-13	CHILDS JOHN W	Director	$24,999,998	3,333,333	+50.9%
2025-11-13	BAILEY GREGORY HUGH	Director	$3,000,000	400,000	+24.7%
2025-11-13	CORIC VLADIMIR	Chief Executive Officer	$4,999,995	666,666	+20.9%

Historical Touches

BHVN has crossed below its 200-week MA 1 time

Crossed Below	Recovered	Weeks	Max Depth	1-Year Return	Return Since Touch
Mar 2025	Ongoing	49+	70.2%	Ongoing	-61.2%

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of Friday close, 2026-02-02